Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ:TELO

Biotechnology

Healthcare
$0.69 -3.42%

-$0.04 today

Market cap
$50.84M
Beta
-0.24
P/E (TTM)
-3.8
EPS (TTM)
-$0.27
52W Low $0.89High $2.09

Volume 0.17M

Average 0.13M

TELO Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

Telomir Pharmaceuticals, Inc. Common StockNASDAQ: TELO

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital growth accelerates

Q1 FY2026 change in working capital of $822.37K (cash outflow) rose 2612.7% year over year, ahead of the -241.2% change in trailing-twelve-month change in working capital. Over 3 fiscal years it compounded at +15.5% a year.

Context

  • Change in working capital increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +2612.7% holds above the trailing-twelve-month pace of -241.2%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$822.37K-194.8% QoQ
Last fiscal yearDec 2025
$594.69K+370.2% YoY
LTMMar 2026
-$168.69K-241.2% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2612.7%——
1 year+370.2%——
3-year CAGR+15.5%——
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
594.69K USD
Year-over-year change
+370.2%
4-year CAGR
+137.4%

Change in Working Capital vs competitors

How TELO compares with its peers on the latest reported figures

  • TELO's LTM Mar 2026 change in working capital of $168.69K is the smallest of the 6 companies compared; the peer median is $2.16M.
  • Its year-over-year change of -241.2% is the 5th highest of 6, against a peer median of -96.1%.
  • Over three fiscal years its annual growth of +15.5% compares with a peer median of +17.2%.
TELO Competitors Peer median
Change in Working Capital for TELO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KPTIKaryopharm Therapeutics Inc.LTM Mar 2026$33.65M +411.5%—22.3%
IPSCCentury Therapeutics, Inc.LTM Mar 2026$4.53M -96.1%——
INMBINmune Bio, Inc.LTM Mar 2026$2.82M -2117.1%-4.0%—
EQEquillium, Inc.LTM Mar 2026$2.16M -139.0%——
COEPCoeptis Therapeutics, Inc.LTM Mar 2026$1.24M +186.3%+38.4%87.6%
TELOTelomir Pharmaceuticals, Inc. Common StockLTM Mar 2026$168.69K -241.2%+15.5%—
Peer median (excluding TELO) $2.16M-96.1%+17.2%55.0%

Competitors are the stored peer set for TELO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(138.13K)(854.15K)(13.07M)(16.53M)(10.41M)
Depreciation & Amortization0004.34M0
Deferred Income Tax00000
Stock-Based Compensation0006.87M5.29M
Change in Working Capital18.74K385.49K113.84K126.47K594.69K
Accounts Receivables00000
Inventory00000
Accounts Payables18.74K0114.56K183.63K(50.77K)
Other Working Capital18.74K385.49K(713)(57.16K)645.46K
Other Non-Cash Items0385.49K9.1M130K840K
Operating Cash Flow(119.4K)(468.66K)(3.86M)(5.07M)(3.69M)
Capital Expenditures(4)0(4)00
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities00000
Investing Cash Flow00000
Debt Repayment0462.39K3.17M(101K)0
Common Stock Issued001M6.83M9.55M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities119.4K7.69K(310.38K)(396.65K)155.52K
Financing Cash Flow119.4K470.08K3.86M6.34M9.71M
Effect of Forex Changes00000
Net Change in Cash01.42K(188)1.26M6.02M
Free Cash Flow(119.4K)(468.66K)(3.86M)(5.07M)(3.69M)

Telomir Pharmaceuticals, Inc. Common Stock

NASDAQ:TELO

Intrinsic Alpha fair value

Locked

Current Price

$0.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.